<p><strong>Geriatrics (&gt; 65 years of age)</strong>: No overall difference in safety and effectiveness has been observed between elderly and other adult patients.<br />
<br />
<strong>Children under the age of 2 years</strong>: The use of Brimonidine Tartrate ophthalmic solution 0.15% in neonates and infants is contraindicated.<br />
<br />
<strong>Children (2-18 years of age)</strong>: The use of Brimonidine Tartrate ophthalmic solution 0.15% is currently not recommended in children</p>